[1]
A. Albert, C. O. Manginstar, D. Saleh, and M. A. Merung, “Neoadjuvant Lenvatinib in Advanced Unresectable Thyroid Carcinoma: Case Series and Literature Review”, eCl, vol. 13, no. 1, pp. 6–11, Jan. 2025.